3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Papillomavirus Infections
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Pancreatic Neoplasms
3
Neoplasms
3
Multiple Myeloma
3
Lymphoma, Follicular
3
Triple Negative Breast Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Lung Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thymic aplasia
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pneumonia
1
Osteosarcoma
1
Obesity
1
Neurofibromatosis 1
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
BNT162 Vaccine
2
2019-nCoV Vaccine mRNA-1273
2
tocilizumab
1
sotrovimab
1
proxalutamide
1
bemcentinib
1
Therapeutics
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Sodium Chloride
1
Radiotherapy
1
Patient Reported Outcome Measures
1
Janus Kinase Inhibitors
1
Influenza Vaccines
1
Hydroxychloroquine
1
HuMax-IL8
1
Gelsolin
1
Diagnostic Tests, Routine
1
Decision Support Techniques
1
COVID-19 Vaccines
1
Blood Specimen Collection
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
COVID-19
×
Blood Specimen Collection
×
Clear all
NCT04427280
2025-09-04
CARDS
Royal Marsden NHS Foundation Trust
Completed
153 enrolled
17 charts